These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 17093066

  • 1. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
    [Abstract] [Full Text] [Related]

  • 2. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC, de Wolff JF, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
    [Abstract] [Full Text] [Related]

  • 3. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 4. Response to mucosal antigen challenge in IgA nephropathy.
    Layward L, Allen AC, Hattersley JM, Harper SJ, Feehally J.
    Exp Nephrol; 1995 Jun; 3(5):300-7. PubMed ID: 7583052
    [Abstract] [Full Text] [Related]

  • 5. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Jun; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 6. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
    Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C.
    J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
    [Abstract] [Full Text] [Related]

  • 7. Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy.
    Barratt J, Bailey EM, Buck KS, Mailley J, Moayyedi P, Feehally J, Turney JH, Crabtree JE, Allen AC.
    Am J Kidney Dis; 1999 Jun; 33(6):1049-57. PubMed ID: 10352192
    [Abstract] [Full Text] [Related]

  • 8. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Jun; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 9. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT, Palle S, Berthoux F.
    Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
    [Abstract] [Full Text] [Related]

  • 10. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
    de Fijter JW, van Nisselrooij NI, Schroeijers WE, Daha MR, van Es LA, van Kooten C.
    Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
    [Abstract] [Full Text] [Related]

  • 11. Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy.
    Allen AC.
    J Nephrol; 1999 Feb; 12(2):76-84. PubMed ID: 10378662
    [Abstract] [Full Text] [Related]

  • 12. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K, Sugiyama S.
    Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
    [Abstract] [Full Text] [Related]

  • 13. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.
    Schena FP, Pastore A, Ludovico N, Sinico RA, Benuzzi S, Montinaro V.
    Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538
    [Abstract] [Full Text] [Related]

  • 14. Pathogenesis of IgA nephropathy.
    Feehally J, Allen AC.
    Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
    [Abstract] [Full Text] [Related]

  • 15. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH.
    Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
    [Abstract] [Full Text] [Related]

  • 16. Deficiency of IgG subclass antibody response to tetanus toxoid associated with high serum IgA levels in IgA nephropathy.
    Layward L, Allen AC, Harper SJ, Hattersley JM, Feehally J.
    Clin Nephrol; 1993 Sep; 40(3):131-6. PubMed ID: 8403566
    [Abstract] [Full Text] [Related]

  • 17. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D, Paradisi L, Baiocchi C, Medana C, Lo Duca G, Sena LM, Roccatello D.
    J Nephrol; 2007 Sep; 20(6):689-95. PubMed ID: 18046671
    [Abstract] [Full Text] [Related]

  • 18. Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy.
    He L, Peng Y, Liu H, Yin W, Chen X, Peng X, Shao J, Liu Y, Liu F.
    Am J Nephrol; 2013 Sep; 38(4):321-32. PubMed ID: 24107646
    [Abstract] [Full Text] [Related]

  • 19. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
    Hiki Y, Ito A, Yamamoto Y, Yamamoto K, Iwase H.
    Adv Otorhinolaryngol; 2011 Sep; 72():68-70. PubMed ID: 21865693
    [Abstract] [Full Text] [Related]

  • 20. Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis.
    Allen AC, Willis FR, Beattie TJ, Feehally J.
    Nephrol Dial Transplant; 1998 Apr; 13(4):930-4. PubMed ID: 9568852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.